Morgan Stanley’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$138M Sell
2,892,204
-435,407
-13% -$20.2M 0.01% 1303
2026
Q1
$146M Buy
3,327,611
+837,278
+34% +$38.2M 0.01% 1132
2025
Q4
$110M Sell
2,490,333
-454,663
-15% -$19.6M 0.01% 1367
2025
Q3
$124M Buy
2,944,996
+368,841
+14% +$14.9M 0.01% 1233
2025
Q2
$94.4M Buy
2,576,155
+403,729
+19% +$15M 0.01% 1371
2025
Q1
$82.7M Sell
2,172,426
-15,177
-0.7% -$565K 0.01% 1387
2024
Q4
$82.8M Buy
2,187,603
+54,130
+3% +$2.16M 0.01% 1399
2024
Q3
$86.8M Sell
2,133,473
-3,900
-0.2% -$148K 0.01% 1353
2024
Q2
$73.2M Buy
2,137,373
+36,876
+2% +$1.16M 0.01% 1400
2024
Q1
$66.5M Buy
2,100,497
+35,813
+2% +$1.09M 0.01% 1500
2023
Q4
$63.3M Sell
2,064,684
-344,950
-14% -$11.1M 0.01% 1494
2023
Q3
$79.9M Buy
2,409,634
+446,227
+23% +$14.3M 0.01% 1208
2023
Q2
$60.3M Sell
1,963,407
-150,422
-7% -$4.35M 0.01% 1429
2023
Q1
$57.9M Sell
2,113,829
-177,629
-8% -$4.94M 0.01% 1423
2022
Q4
$64M Sell
2,291,458
-119,026
-5% -$3.59M 0.01% 1305
2022
Q3
$71.1M Buy
2,410,484
+63,315
+3% +$1.98M 0.01% 1086
2022
Q2
$66.2M Buy
2,347,169
+1,212,495
+107% +$34.5M 0.01% 1191
2022
Q1
$35.4M Buy
1,134,674
+15,338
+1% +$452K ﹤0.01% 1554
2021
Q4
$33.1M Sell
1,119,336
-292,049
-21% -$8.53M ﹤0.01% 1664
2021
Q3
$42.3M Buy
1,411,385
+159,694
+13% +$5.49M 0.01% 1412
2021
Q2
$45.4M Buy
1,251,691
+145,052
+13% +$5.39M 0.01% 1385
2021
Q1
$40.5M Sell
1,106,639
-243,056
-18% -$8.95M 0.01% 1328
2020
Q4
$49M Buy
1,349,695
+521,037
+63% +$17.7M 0.01% 1118
2020
Q3
$24.8M Sell
828,658
-87,150
-10% -$2.72M ﹤0.01% 1320
2020
Q2
$27.2M Sell
915,808
-102,893
-10% -$3.05M 0.01% 1195
2020
Q1
$27M Buy
1,018,701
+75,297
+8% +$2.86M 0.01% 1081
2019
Q4
$40M Buy
943,404
+41,407
+5% +$1.75M 0.01% 1098
2019
Q3
$37.7M Buy
901,997
+150,909
+20% +$5.88M 0.01% 1031
2019
Q2
$27.6M Buy
751,088
+39,222
+6% +$1.43M 0.01% 1245
2019
Q1
$27.2M Sell
711,866
-96,676
-12% -$3.58M 0.01% 1225
2018
Q4
$28.4M Sell
808,542
-208,533
-21% -$7.23M 0.01% 1169
2018
Q3
$33.3M Buy
1,017,075
+23,415
+2% +$745K 0.01% 1243
2018
Q2
$30.8M Sell
993,660
-257,435
-21% -$7.36M 0.01% 1235
2018
Q1
$33.8M Sell
1,251,095
-812,952
-39% -$21.7M 0.01% 1210
2017
Q4
$56.8M Buy
2,064,047
+497,628
+32% +$14.4M 0.02% 873
2017
Q3
$50M Buy
1,566,419
+107,702
+7% +$3.45M 0.02% 904
2017
Q2
$48.2M Sell
1,458,717
-2,229,278
-60% -$73.8M 0.01% 930
2017
Q1
$122M Buy
3,687,995
+59,077
+2% +$1.9M 0.04% 493
2016
Q4
$113M Sell
3,628,918
-1,729,484
-32% -$53.4M 0.04% 484
2016
Q3
$190M Buy
5,358,402
+780,102
+17% +$27.7M 0.06% 327
2016
Q2
$155M Buy
4,578,300
+2,061,395
+82% +$68.8M 0.06% 368
2016
Q1
$88.8M Buy
2,516,905
+233,604
+10% +$7.65M 0.03% 511
2015
Q4
$79.9M Buy
2,283,301
+55,040
+2% +$1.9M 0.03% 577
2015
Q3
$78.3M Sell
2,228,261
-230,567
-9% -$8.1M 0.03% 575
2015
Q2
$84.4M Buy
2,458,828
+151,175
+7% +$5.55M 0.03% 581
2015
Q1
$93.6M Buy
2,307,653
+169,497
+8% +$7.02M 0.03% 528
2014
Q4
$83.5M Sell
2,138,156
-141,741
-6% -$5.37M 0.03% 591
2014
Q3
$77.9M Buy
2,279,897
+365,416
+19% +$13.4M 0.03% 617
2014
Q2
$70.6M Buy
1,914,481
+22,268
+1% +$795K 0.03% 635
2014
Q1
$63.4M Sell
1,892,213
-333,311
-15% -$10.6M 0.03% 639
2013
Q4
$66.3M Sell
2,225,524
-16,377
-0.7% -$519K 0.03% 612
2013
Q3
$67M Buy
2,241,901
+255,078
+13% +$7.76M 0.03% 558
2013
Q2
$61.6M Buy
+1,986,823
New +$65.3M 0.03% 562

Other funds holding OHI

Morgan Stanley's OHI Position: Q2 2026 in Review

Morgan Stanley reduced its Omega Healthcare (OHI) stake by 13% in Q2 2026, selling an estimated $20.2M and leaving 2,892,204 shares worth $138M. The position accounts for 0.01% of the portfolio, ranked #1303.

Morgan Stanley first reported a position in OHI in Q2 2013 and has held it in 53 quarters since. The position peaked at $190M in Q3 2016. 759 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Morgan Stanley held 2,892,204 shares of Omega Healthcare worth $138M as of Q2 2026.
  • Morgan Stanley sold 435,407 Omega Healthcare shares in Q2 2026, an estimated $20.2M.
  • Omega Healthcare made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1303 holding.
  • Morgan Stanley first reported a position in Omega Healthcare in Q2 2013 and has held it in 53 quarters since.
  • Morgan Stanley's Omega Healthcare position peaked at $190M in Q3 2016.
  • 759 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.